[{"id":"8cbaeb2f-65c4-4a58-98fe-a12c3fec7f28","acronym":"","url":"https://clinicaltrials.gov/study/NCT05472857","created_at":"2022-07-25T20:54:35.084Z","updated_at":"2024-07-02T16:35:16.126Z","phase":"Phase 1","brief_title":"Clinical Study of CLDN18.2-targeting CAR T Cells in Advanced Solid Tumors With Positive CLDN18.2 Expression","source_id_and_acronym":"NCT05472857","lead_sponsor":"Suzhou Immunofoco Biotechnology Co., Ltd","biomarkers":" CLDN18","pipe":"","alterations":" ","tags":["CLDN18"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e IMC002"],"overall_status":"Recruiting","enrollment":" Enrollment 30","initiation":"Initiation: 08/08/2022","start_date":" 08/08/2022","primary_txt":" Primary completion: 12/01/2024","primary_completion_date":" 12/01/2024","study_txt":" Completion: 12/01/2024","study_completion_date":" 12/01/2024","last_update_posted":"2024-03-06"},{"id":"ce53abad-b3e8-4c4b-9177-ef32c0764dd3","acronym":"","url":"https://clinicaltrials.gov/study/NCT05946226","created_at":"2023-07-14T18:09:04.276Z","updated_at":"2024-07-02T16:35:35.396Z","phase":"Phase 1","brief_title":"A Phase I Trial to Evaluate the Safety of IMC002 in Advanced Digestive System Tumors","source_id_and_acronym":"NCT05946226","lead_sponsor":"Suzhou Immunofoco Biotechnology Co., Ltd","biomarkers":" CLDN18 • IL6 • IL2 • IL10","pipe":" | ","alterations":" CLDN18.2 positive","tags":["CLDN18 • IL6 • IL2 • IL10"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e CLDN18.2 positive"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e IMC001 • IMC002 • danburstotug (IMC-001)"],"overall_status":"Recruiting","enrollment":" Enrollment 18","initiation":"Initiation: 09/07/2023","start_date":" 09/07/2023","primary_txt":" Primary completion: 12/01/2025","primary_completion_date":" 12/01/2025","study_txt":" Completion: 12/31/2025","study_completion_date":" 12/31/2025","last_update_posted":"2023-09-28"}]